We are live on
!
Find out more
SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
1-Year Est. Return
0.56%
This Fund
S&P 500
This Quarter
Est. Return
-2.83%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$377M
AUM Growth
-$9.7M
(-2.5%)
Cap. Flow
-$133K
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
73.26%
Holding
43
New
8
Increased
13
Reduced
9
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$20.8M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$18.1M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$10.7M |
| 4 |
SHPG
Shire pic
SHPG
|
+$10.4M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$9.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$14.3M |
| 2 |
ELGX
Endologix Inc
ELGX
|
+$13.9M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$13.5M |
| 4 |
Bausch Health
BHC
|
+$12M |
| 5 |
Molina Healthcare
MOH
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 97.01% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rocket Pharmaceuticals
RCKT
$346M
| $2.52M | 0.67% |
103,106
-300
| -0.3% | -$8.56K |
|
|
VXRT
27
DELISTED
Vaxart
VXRT
| $2.18M | 0.58% |
161,352
-464
| -0.3% | -$7.09K |
|
|
ZGNX
28
DELISTED
Zogenix, Inc.
ZGNX
| $1.92M | 0.51% |
158,100
+20,200
| +15% | +$222K |
|
|
PRTK
29
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.92M | 0.51% |
124,519
+7,500
| +6% | +$97.4K |
|
|
AAAP
30
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $385K | 0.1% |
+14,400
| New | +$484K |
|
|
31
Bausch Health
BHC
$1.68B
| – | – |
-488,900
| Closed | -$12M |
|
|
32
Enanta Pharmaceuticals
ENTA
$367M
| – | – |
-506,900
| Closed | -$13.5M |
|
33
Insmed
INSM
$22.6B
| – | – |
-593,336
| Closed | -$8.62M |
|
|
34
Molina Healthcare
MOH
$10.5B
| – | – |
-179,700
| Closed | -$10.5M |
|
35
Rigel Pharmaceuticals
RIGL
$709M
| – | – |
-90,720
| Closed | -$3.33M |
|
|
SEM
36
DELISTED
Select Medical
SEM
| – | – |
-512,998
| Closed | -$3.73M |
|
37
Tandem Diabetes Care
TNDM
$1.22B
| – | – |
-45,541
| Closed | -$3.49M |
|
38
Viatris
VTRS
$20.8B
| – | – |
-273,500
| Closed | -$10.4M |
|
|
ACOR
39
DELISTED
Acorda Therapeutics
ACOR
| – | – |
-1,596
| Closed | -$4M |
|
|
ARRY
40
DELISTED
Array Biopharma Inc
ARRY
| – | – |
-627,100
| Closed | -$4.23M |
|
|
ELGX
41
DELISTED
Endologix Inc
ELGX
| – | – |
-108,770
| Closed | -$13.9M |
|
|
AET
42
DELISTED
Aetna Inc
AET
| – | – |
-123,600
| Closed | -$14.3M |
|
|
ADPT
43
DELISTED
Adeptus Health Inc
ADPT
| – | – |
-163,700
| Closed | -$7.05M |
|
Similar funds
BCP
PRHC
NAM
GG
SM
BC
SCPM
FAM
Senzar Asset Management's Q4 2016 Portfolio in Review
As of Q4 2016, Senzar Asset Management held 43 positions worth $377M, down 2.5% from $387M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Senzar Asset Management's Q4 2016 filing shows 8 new, 13 increased, 9 reduced and 13 closed positions. Its largest new stake was MALLINCKRODT PUBLIC LIMITED COMPANY: 306,500 shares worth $15.3M. The largest sale was Aetna Inc, an estimated $14.3M.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 90% a quarter earlier, followed by Financials.
- Senzar Asset Management's largest Q4 2016 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 306,500 shares worth $15.3M.
- Senzar Asset Management added most to Allergan plc in Q4 2016, an estimated $20.8M increase.
- Senzar Asset Management's biggest Q4 2016 reduction was Sanofi, cutting an estimated $7.9M.
- Senzar Asset Management fully exited Aetna Inc in Q4 2016, selling an estimated $14.3M.
- Senzar Asset Management's ten largest holdings make up 73% of its $377M portfolio in Q4 2016.
- Senzar Asset Management opened 8 new positions and closed 13 in Q4 2016.
- Senzar Asset Management's portfolio value fell 2.5% quarter-over-quarter to $377M.
Based on Senzar Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.